Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC breast cancer coooperative group
Authors:
- 1 May 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (5) , 595-599
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Phase II clinical trial of cis-dichlorodiammine platinum (cis-DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancerCancer Chemotherapy and Pharmacology, 1983
- Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II studyEuropean Journal of Cancer and Clinical Oncology, 1982
- Cisplatin in the treatment of metastatic breast carcinoma A prospective randomized trial of two dosage schedulesAmerican Journal of Clinical Oncology, 1982
- High-dose dexamethasone for prevention of cis-platin-induced vomitingCancer Chemotherapy and Pharmacology, 1981
- The Role of cis-Platinum in Solid-Tumor TherapyNew England Journal of Medicine, 1979
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977